Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

10.1K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.1K
T Cell Types and Functions01:24

T Cell Types and Functions

3.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.2K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

7.1K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.1K
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

14.3K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
14.3K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

13.6K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
13.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of the ETV5/p38 Signaling Axis in Aggressive Thyroid Cancer Cells.

Molecular cancer therapeutics·2026
Same author

Link between dysbiosis and cancer: Contributing mechanisms and factors.

International review of cell and molecular biology·2025
Same author

Role of the ETV5/p38 signaling axis in aggressive thyroid cancer cells.

bioRxiv : the preprint server for biology·2025
Same author

Toxicity in the era of immune checkpoint inhibitor therapy.

Frontiers in immunology·2024
Same author

Author Correction: Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy.

Nature communications·2024
Same author

Emerging therapeutic options for follicular-derived thyroid cancer in the era of immunotherapy.

Frontiers in immunology·2024

Related Experiment Video

Updated: Apr 25, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

7.6K

Grail controls Th2 cell development by targeting STAT6 for degradation.

Anupama Sahoo1, Andrei Alekseev1, Lidiya Obertas1

  • 1Department of Immunology, M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

Nature Communications
|August 23, 2014
PubMed
Summary

Grail, an E3 ubiquitin ligase, controls T helper 2 cell development. Grail deficiency increases allergic asthma susceptibility by enhancing Th2 effector cytokines and Stat6 levels.

More Related Videos

In Vitro Differentiation of Mouse Granulocyte-macrophage-colony-stimulating Factor GM-CSF-producing T Helper THGM Cells
10:27

In Vitro Differentiation of Mouse Granulocyte-macrophage-colony-stimulating Factor GM-CSF-producing T Helper THGM Cells

Published on: September 10, 2018

6.6K
Author Spotlight: Achieving High-Purity In Vitro Differentiation of Th17 Cells Using Cytokine Concentration Modulation
07:46

Author Spotlight: Achieving High-Purity In Vitro Differentiation of Th17 Cells Using Cytokine Concentration Modulation

Published on: October 25, 2024

3.2K

Related Experiment Videos

Last Updated: Apr 25, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

7.6K
In Vitro Differentiation of Mouse Granulocyte-macrophage-colony-stimulating Factor GM-CSF-producing T Helper THGM Cells
10:27

In Vitro Differentiation of Mouse Granulocyte-macrophage-colony-stimulating Factor GM-CSF-producing T Helper THGM Cells

Published on: September 10, 2018

6.6K
Author Spotlight: Achieving High-Purity In Vitro Differentiation of Th17 Cells Using Cytokine Concentration Modulation
07:46

Author Spotlight: Achieving High-Purity In Vitro Differentiation of Th17 Cells Using Cytokine Concentration Modulation

Published on: October 25, 2024

3.2K

Area of Science:

  • Immunology
  • Molecular Biology

Background:

  • T helper (Th)2 cells are central to allergic asthma pathogenesis.
  • Mechanisms regulating Th2-mediated inflammation remain incompletely understood.

Purpose of the Study:

  • To investigate the role of Grail, an E3 ubiquitin ligase, in Th2 cell function and allergic asthma.
  • To elucidate the regulatory mechanisms controlling Grail expression and function in Th2 cells.

Main Methods:

  • Analysis of Grail expression in Th2 cells.
  • Investigation of Grail's interaction with Stat6 via ubiquitination and degradation assays.
  • Assessment of Grail-deficient mice susceptibility to allergic asthma models.

Main Results:

  • Grail expression in Th2 cells is upregulated by interleukin-4 (IL-4) signaling components, including signal transducer and activator of transcription 6 (Stat6) and Gata3.
  • Grail deficiency in T cells results in elevated Th2 effector cytokines and increased susceptibility to allergic asthma.
  • Grail targets Stat6 for ubiquitination and degradation, thereby regulating its expression.

Conclusions:

  • Grail acts as a critical negative regulator of Th2 cell development and function.
  • Grail controls Th2-mediated inflammation and allergic asthma severity through a negative feedback loop involving Stat6 degradation.